Is Strive Pharmacy a registered 503B outsourcing facility?

Is Strive Pharmacy a licensed 503B outsourcing facility?

FDA’s registered outsourcing facility list (updated Nov 6, 2026) names Strive Outsourcing LLC in Alachua, FL, first registered Oct 23, 2026 and not yet inspected; that is an FDA registration, while pharmacy licenses come from state boards. FDA’s compounding actions page lists Strive Pharmacy Texas, LLC, dba Strive Pharmacy (formerly Talon Pharmacy of Boerne) in Boerne, TX as a 503A facility, and FDA issued Strive Pharmacy Texas a close-out letter on May 13, 2026 for a warning letter dated August 29, 2022.

FDA’s records do not say whether Strive Outsourcing LLC and Strive Pharmacy Texas, LLC are related companies. Each is listed under its own legal name and address.

The close-out letter is listed on FDA’s actions page under Vita Pharmacy, LLC, (dba Talon Compounding Pharmacy), San Antonio, TX. FDA addressed it to Strive Pharmacy Texas LLC dba Strive Pharmacy and Vita Pharmacy, LLC dba Talon Pharmacy of Boerne, and wrote that the firm appears to have adequately addressed the violations in warning letter 639220. Read the close-out letter on fda.gov.

Strive Pharmacy Texas, LLC, dba Strive Pharmacy (formerly Talon Pharmacy of Boerne), Boerne, TX (503A)

FDA’s compounding inspections and actions page lists 1 action for this entry.

Document
Sep 8, 2023Form 483483 Issued 09/08/2023FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination.

Vita Pharmacy, LLC, (dba Talon Pharmacy of Boerne), Boerne, TX (503A)

FDA’s compounding inspections and actions page lists 4 actions for this entry.

Document
Aug 29, 2022Warning letterWarning Letter (08/29/2022)FDA copy (archived)
Nov 2, 2021Form 483483 Issued 11/02/2021FDA copy (archived)
Jul 8, 2020FMD-145 letterFMD-145 Letter Issued 07/08/2020fda.gov
Feb 11, 2020Form 483483 Issued 02/11/2020FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.

On FDA’s registered 503B list

GLP-1 warning letters and recalls under this name

No FDA warning letter or openFDA recall report naming a GLP-1 drug in this index carries this name, as of Nov 15, 2026.

These records share a name. FDA lists each under its own legal name and address, and the records do not say how the entities are related.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.

Common questions

Is a 503B registration a license?

No. Outsourcing facilities register with FDA under section 503B; pharmacy licenses are issued by state boards of pharmacy. FDA’s 503B list does not show state licenses.

How do I check whether any pharmacy is a 503B outsourcing facility?

Search FDA’s registered outsourcing facility list, which names 100 facilities as of Nov 6, 2026. Steps are on the page on checking 503B registration.